KLK4 and angioedema: All types of HAEnCI mutations seem to affect the pathways of the fibrinolytic and kallikrein-kinin system at different levels, leading to bradykinin-mediated vascular leakage and angioedema formation via activation of the bradykinin B2 receptor (Fig. 1).